logo

For the Inventor, By the Inventor

Nagoya, Japan

Tsunemasa Suzuki

This inventor holds 6 USPTO granted patents. Top assignee: Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 1987-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tsunemasa Suzuki. Retrieved from https://idiyas.com/inventor/tsunemasa-suzuki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 7.4

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Kumamoto, JP (1987)
  • Matsubase, JP (1989)
  • Aichi, JP (1992 - 1995)
  • Nagoya, JP (1990 - 1996)

Company Filing History:

goldMedal6 out of 108 
 
Sanwa Kagaku Kenkyusho Co., Ltd.
 patents

Years Active: 1987-1996

Loading Chart...
6 patents (USPTO):Explore Patents
1. 5530138 - Compounds and use thereof (1996-06-25),
2. 5434165 - Nootropic agents, compositions of, and method of use thereof (1995-07-18),
3. 5164391 - Hydantoin derivatives for treating complications of diabetes and (1992-11-17),
4. 4939126 - 1-pyrrolidineacetamide derivatives and use thereof (1990-07-03),
5. 4824855 - 1,4-dihydropyridine derivatives (1989-04-25),
6. 4678801 - Novel 2-oxopyrrolidine compounds, salts thereof process for the (1987-07-07),

Title: Tsunemasa Suzuki: Innovator in Pharmaceutical Compounds

Introduction

Tsunemasa Suzuki is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating neurodegenerative diseases. With a total of 6 patents to his name, his work has the potential to impact the lives of many individuals suffering from conditions such as Alzheimer's disease.

Latest Patents

One of Tsunemasa Suzuki's latest patents involves compounds that bind with muscarinic receptors in the brain. This innovation aims to develop a powerful actuation of these receptors, making it an effective ingredient for preventing and curing senile dementias, particularly Alzheimer's disease. Another significant patent focuses on nootropic agents, which are aromatic amino-substituted compounds designed to enhance cognitive function. These compounds are represented by complex chemical formulas that highlight their potential therapeutic applications.

Career Highlights

Throughout his career, Tsunemasa Suzuki has been associated with Sanwa Kagaku Kenkyusho Co., Ltd., where he has been able to apply his expertise in pharmaceutical research. His innovative approach to drug development has garnered attention in the scientific community, and his patents reflect his commitment to advancing medical science.

Collaborations

Tsunemasa Suzuki has collaborated with several esteemed colleagues in his field, including Masayasu Kurono and Kiichi Sawai. These partnerships have allowed for a rich exchange of ideas and have contributed to the success of his research endeavors.

Conclusion

Tsunemasa Suzuki's work in developing pharmaceutical compounds showcases his dedication to addressing critical health issues. His innovative patents and collaborations highlight the importance of research in the fight against neurodegenerative diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…